{
  "code": "MED",
  "name": "Media/Publishing",
  "totalSpending": 203833223.44,
  "totalFilings": 9746,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 19399052,
      "filings": 995
    },
    {
      "year": 2019,
      "income": 20093968.42,
      "filings": 1065
    },
    {
      "year": 2020,
      "income": 26263050,
      "filings": 1359
    },
    {
      "year": 2021,
      "income": 27414500,
      "filings": 1295
    },
    {
      "year": 2022,
      "income": 29389606.84,
      "filings": 1364
    },
    {
      "year": 2023,
      "income": 27146096.18,
      "filings": 1309
    },
    {
      "year": 2024,
      "income": 24234200,
      "filings": 1123
    },
    {
      "year": 2025,
      "income": 29892750,
      "filings": 1236
    }
  ],
  "topClients": [
    {
      "name": "COALITION OF EPSCOR STATES",
      "income": 3560000
    },
    {
      "name": "AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA)",
      "income": 2830000
    },
    {
      "name": "MASS GENERAL BRIGHAM",
      "income": 2695000
    },
    {
      "name": "OMEROS CORPORATION",
      "income": 2385000
    },
    {
      "name": "ALLIANCE FOR BIOSECURITY",
      "income": 2350000
    },
    {
      "name": "AIR LIQUIDE USA LLC",
      "income": 2338000
    },
    {
      "name": "TRAVERE THERAPEUTICS",
      "income": 2325000
    },
    {
      "name": "PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION",
      "income": 2280000
    },
    {
      "name": "LOMA LINDA UNIVERSITY MEDICAL CENTER",
      "income": 2103367
    },
    {
      "name": "UAB HEALTH SYSTEM",
      "income": 1850000
    },
    {
      "name": "AMGEN USA, INC.",
      "income": 1840000
    },
    {
      "name": "SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION",
      "income": 1760000
    },
    {
      "name": "CONTINUING MEDICAL EDUCATION COALITION",
      "income": 1740000
    },
    {
      "name": "IQVIA",
      "income": 1730000
    },
    {
      "name": "SANOFI, U.S.",
      "income": 1690000
    },
    {
      "name": "CHILDREN'S NATIONAL MEDICAL CENTER",
      "income": 1600000
    },
    {
      "name": "ASTCT",
      "income": 1590000
    },
    {
      "name": "MEDISYS HEALTH NETWORK",
      "income": 1588536.0199999998
    },
    {
      "name": "ASSOCIATION FOR MOLECULAR PATHOLOGY",
      "income": 1571000
    },
    {
      "name": "JAZZ PHARMACEUTICALS",
      "income": 1550000
    },
    {
      "name": "INVITAE INC.",
      "income": 1475500
    },
    {
      "name": "EXELA PHARMA SCIENCES, LLC",
      "income": 1452000
    },
    {
      "name": "AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION",
      "income": 1450000
    },
    {
      "name": "MISSISSIPPI STATE UNIVERSITY",
      "income": 1350000
    },
    {
      "name": "UNIVERSITY OF ALABAMA SYSTEM",
      "income": 1280000
    },
    {
      "name": "CITY OF HOPE MEDICAL CENTER",
      "income": 1250000
    },
    {
      "name": "AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE",
      "income": 1190000
    },
    {
      "name": "MYRIAD GENETICS, INC.",
      "income": 1180000
    },
    {
      "name": "CSL BEHRING",
      "income": 1170000
    },
    {
      "name": "QORVO",
      "income": 1170000
    },
    {
      "name": "NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION)",
      "income": 1110000
    },
    {
      "name": "MEDICAL UNIVERSITY HOSPITAL AUTHORITY",
      "income": 1100000
    },
    {
      "name": "ABBVIE, INC.",
      "income": 1100000
    },
    {
      "name": "CARIS SCIENCE INC",
      "income": 1080000
    },
    {
      "name": "APIJECT SYSTEMS CORP.",
      "income": 1080000
    },
    {
      "name": "ADVANCED MEDICAL TECHNOLOGY ASSOCIATION",
      "income": 1050000
    },
    {
      "name": "UNITED FOR MEDICAL RESEARCH",
      "income": 1020000
    },
    {
      "name": "SANFORD HEALTH",
      "income": 1010000
    },
    {
      "name": "COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION",
      "income": 1000000
    },
    {
      "name": "PANCREATIC CANCER ACTION NETWORK (PANCAN)",
      "income": 990000
    },
    {
      "name": "AMERICAN SOCIETY FOR RADIATION ONCOLOGY",
      "income": 970000
    },
    {
      "name": "BLUE EARTH DIAGNOSTICS, INC.",
      "income": 960000
    },
    {
      "name": "LSU HEALTH SCIENCES FOUNDATION",
      "income": 960000
    },
    {
      "name": "GINKGO BIOWORKS, INC.",
      "income": 960000
    },
    {
      "name": "LABORATORY CORPORATIONS OF AMERICA HOLDINGS",
      "income": 940000
    },
    {
      "name": "TENET BUSINESS SERVICES CORPORATION",
      "income": 930000
    },
    {
      "name": "HOLISTIC INDUSTRIES INC.",
      "income": 930000
    },
    {
      "name": "LIFESCIENCE LOGISTICS",
      "income": 930000
    },
    {
      "name": "VERTEX PHARMACEUTICALS INCORPORATED",
      "income": 900000
    },
    {
      "name": "MEDICAL COLLEGE OF WISCONSIN",
      "income": 900000
    }
  ],
  "topFirms": [
    {
      "name": "CORNERSTONE GOVERNMENT AFFAIRS, INC.",
      "income": 13730000
    },
    {
      "name": "VAN SCOYOC ASSOCIATES",
      "income": 11040000
    },
    {
      "name": "FORBES-TATE",
      "income": 7140000
    },
    {
      "name": "THE PETRIZZO GROUP, INC.",
      "income": 6570000
    },
    {
      "name": "BROWNSTEIN HYATT FARBER SCHRECK, LLP",
      "income": 6320000
    },
    {
      "name": "WILLIAMS AND JENSEN, PLLC",
      "income": 6070000
    },
    {
      "name": "SQUIRE PATTON BOGGS",
      "income": 5290000
    },
    {
      "name": "BALLARD PARTNERS",
      "income": 4890000
    },
    {
      "name": "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",
      "income": 4820000
    },
    {
      "name": "THORN RUN PARTNERS",
      "income": 3910000
    },
    {
      "name": "CAPITOL COUNSEL LLC",
      "income": 3880000
    },
    {
      "name": "MANATT, PHELPS, AND PHILLIPS",
      "income": 3751903.02
    },
    {
      "name": "O'NEILL, ATHY & CASEY, P.C.",
      "income": 3475000
    },
    {
      "name": "IPOLICY SOLUTIONS",
      "income": 3380250
    },
    {
      "name": "ALSTON & BIRD LLP",
      "income": 3330000
    },
    {
      "name": "BRACEWELL LLP",
      "income": 3198000
    },
    {
      "name": "COVINGTON & BURLING LLP",
      "income": 3080000
    },
    {
      "name": "THE CONAFAY GROUP, LLC",
      "income": 2710000
    },
    {
      "name": "POWERS PYLES SUTTER & VERVILLE, P.C.",
      "income": 2690000
    },
    {
      "name": "IMPACT HEALTH POLICY PARTNERS",
      "income": 2480000
    },
    {
      "name": "HOLLAND & KNIGHT LLP",
      "income": 2430000
    },
    {
      "name": "BUCHANAN INGERSOLL & ROONEY PC",
      "income": 2000000
    },
    {
      "name": "TIBER CREEK GROUP",
      "income": 1830000
    },
    {
      "name": "REPUBLIC CONSULTING, LLC",
      "income": 1730000
    },
    {
      "name": "FOLEY & LARDNER LLP",
      "income": 1696000
    },
    {
      "name": "CROSSROADS STRATEGIES, LLC",
      "income": 1640000
    },
    {
      "name": "RAMPY NORTHRUP LLC",
      "income": 1630000
    },
    {
      "name": "SMITHBUCKLIN CORPORATION",
      "income": 1590000
    },
    {
      "name": "TODD STRATEGY GROUP",
      "income": 1530000
    },
    {
      "name": "ARTEMIS POLICY GROUP LLC",
      "income": 1520000
    }
  ],
  "sampleDescriptions": [
    "Raising Canndescent's profile in Washington, DC with federal decision makers; intellectual property issues before the US Patent and Trademark Office; promoting Canndescent's research and development o",
    "Development of government-private partnerships to advance Alzheimer's therapies.",
    "Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition.",
    "Issues related to hospital and other provider-related reimbursement, including: graduate medical education, value-based purchasing programs, post acute care, and inclusion of unique device identifiers",
    "Medicare payment for hyperbaric oxygen therapy;\nUse of hyperbaric oxygen therapy for treatment of PTSD and CTE;\nResearch on effectiveness of HBOT for PTSD and CTE for active duty and retired and disab",
    "Issues related to payment and delivery reforms, Medicaid benefits and childrens hospital reimbursement. Issues related to pediatric research and childrens hospital graduate medical education.",
    "Issues related to FDA diagnostics approval process",
    "Veterans administration (structure, benefits, services, and quality of care)   Family code (UCCJEA) Federal enforcement of parental rights. Veteran suicide epidemic (root causes, actions, programs, ac",
    "FY19 DoD Appropriations;\nFY19 Labor, HHS, Education Appropriations;\nFY19 NDAA;\nIssues related to autism research",
    "Federal government relations service, strategy development and implementation relating to companys status of FDA action on NDA for oral testosterone.",
    "state, foreign ops appropriations; HIV/AIDS-related issues",
    "Educate policymakers and congressional committees on MedStar Health and importance ensuring critical medical transportation and trauma services in the National Capital Region. Work with federal agenci",
    "Issues related to cervical cancer screening.",
    "Drug FDA Approval: CAM2038",
    "Federal government relations service, strategy development and implementation relating to status of FDAs action with regards to the companys NDA.",
    "Federal government relations service, strategy development and implementation relating to regenerative medicine products.",
    "Issues related to medical devices and lab developed tests.",
    "Medicare/Medicaid drug coverage, opioid addiction policy, S.2456 The CARA 2.0 Act of 2018.",
    "Biodefense, Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing, infectious diseases, cancer, PAHPA, Labor-HHS Appropriations bil",
    "Appropriations for National Asthma Control Program at CDC, H.R. 2285, School Based Respiratory Health Management Act"
  ],
  "quarterlyTrend": [
    {
      "quarter": "2018-first_quarter",
      "filings": 253,
      "spending": 4048432.172055721
    },
    {
      "quarter": "2018-fourth_quarter",
      "filings": 244,
      "spending": 4112811.660095492
    },
    {
      "quarter": "2018-second_quarter",
      "filings": 240,
      "spending": 4238147.203640805
    },
    {
      "quarter": "2018-third_quarter",
      "filings": 258,
      "spending": 4700301.328265932
    },
    {
      "quarter": "2019-first_quarter",
      "filings": 238,
      "spending": 3931827.414303125
    },
    {
      "quarter": "2019-fourth_quarter",
      "filings": 287,
      "spending": 4810106.311571924
    },
    {
      "quarter": "2019-second_quarter",
      "filings": 254,
      "spending": 4200570.2746407
    },
    {
      "quarter": "2019-third_quarter",
      "filings": 286,
      "spending": 4617215.983663763
    },
    {
      "quarter": "2020-first_quarter",
      "filings": 297,
      "spending": 4628883.371833722
    },
    {
      "quarter": "2020-fourth_quarter",
      "filings": 350,
      "spending": 5530173.526264176
    },
    {
      "quarter": "2020-second_quarter",
      "filings": 342,
      "spending": 5721198.592182494
    },
    {
      "quarter": "2020-third_quarter",
      "filings": 370,
      "spending": 5888751.659839677
    },
    {
      "quarter": "2021-first_quarter",
      "filings": 297,
      "spending": 4872753.179805194
    },
    {
      "quarter": "2021-fourth_quarter",
      "filings": 330,
      "spending": 5838823.909069263
    },
    {
      "quarter": "2021-second_quarter",
      "filings": 321,
      "spending": 4593282.061721612
    },
    {
      "quarter": "2021-third_quarter",
      "filings": 347,
      "spending": 5489193.836652241
    },
    {
      "quarter": "2022-first_quarter",
      "filings": 322,
      "spending": 5941674.108279293
    },
    {
      "quarter": "2022-fourth_quarter",
      "filings": 335,
      "spending": 6992012.4214918
    },
    {
      "quarter": "2022-second_quarter",
      "filings": 348,
      "spending": 6147272.281306804
    },
    {
      "quarter": "2022-third_quarter",
      "filings": 359,
      "spending": 6839706.502079854
    },
    {
      "quarter": "2023-first_quarter",
      "filings": 329,
      "spending": 5976514.999121171
    },
    {
      "quarter": "2023-fourth_quarter",
      "filings": 333,
      "spending": 5778108.429307827
    },
    {
      "quarter": "2023-second_quarter",
      "filings": 331,
      "spending": 6052528.271656122
    },
    {
      "quarter": "2023-third_quarter",
      "filings": 316,
      "spending": 5541252.54727191
    },
    {
      "quarter": "2024-first_quarter",
      "filings": 260,
      "spending": 5288323.722420051
    },
    {
      "quarter": "2024-fourth_quarter",
      "filings": 292,
      "spending": 5116454.317862694
    },
    {
      "quarter": "2024-second_quarter",
      "filings": 278,
      "spending": 5239315.211787878
    },
    {
      "quarter": "2024-third_quarter",
      "filings": 293,
      "spending": 5021181.539221886
    },
    {
      "quarter": "2025-first_quarter",
      "filings": 253,
      "spending": 4586044.17768198
    },
    {
      "quarter": "2025-fourth_quarter",
      "filings": 324,
      "spending": 7179534.244604576
    },
    {
      "quarter": "2025-second_quarter",
      "filings": 326,
      "spending": 6242282.678171829
    },
    {
      "quarter": "2025-third_quarter",
      "filings": 333,
      "spending": 7103432.813664112
    }
  ],
  "totalEstimatedSpending": 172268111
}